You are here: Industry Insights > Clinical Trial

News List

49 per cent of clinical trial disruption due to slow enrollment- GlobalData expresspharma
December 22, 2020
The fastest rate of trial disruption was between early April and mid-May, and the number of trials disrupted by COVID-19 peaked in the first week of June
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment prnasia
December 21, 2020
The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being developed by ImmuneMed, is on track to progress as a treatment for the COVID-19 pneumonia patients.
NIH-sponsored trials evaluate monoclonal antibodies for Covid-19 treatment pharmaceutical-technology
December 18, 2020
The National Institutes of Health (NIH) in the US has announced the initiation of two Phase III clinical trials analysing investigational monoclonal antibodies for treating people hospitalised with moderate Covid-19.
NeuroTherapia Completes NTRX-07 Phase 1a Clinical Trial americanpharmaceuticalreview
December 18, 2020
NeuroTherapia announced the completion of its first-in-human study of NTRX-07. This study was a single ascending dose clinical trial carried out in healthy volunteers.
Therapeutic Solutions Announces Positive QuadraMune Clinical Trial Data americanpharmaceuticalreview
December 18, 2020
Therapeutics Solution International announced new data from its clinical trial demonstrating an almost doubling of immune cell activity in healthy volunteers which were ingesting QuadraMune™ daily for a week.
COVAXIN is well tolerated with no serious adverse events in Phase I trials expresspharma
December 18, 2020
The trial was conducted on volunteers from diverse geographic locations and socioeconomic conditions, enrolling 375 participants across 11 hospitals.
AstroRx® shows promise in early phase amyotrophic lateral sclerosis trial europeanpharmaceuticalreview
December 17, 2020
Amyotrophic lateral sclerosis (ALS) patients treated with AstroRx® had a 45 percent reduction in their disease progression rate.
First Patient Dosed in Trial of Ultra-Concentrated Rapid Acting Insulin Candidate for Diabetes americanpharmaceuticalreview
December 17, 2020
Arecor Limited has announced dosing of the first patient in a Phase I clinical trial for its second clinical stage product, an ultra-concentrated rapid acting insulin, AT278.
Thermo Fisher Expands Clinical Supply Services in Europe contractpharma
December 16, 2020
The new sites will bring much-needed clinical supply chain continuity and specialized cold chain and cryogenic expertise across Europe and globally.
Universal influenza vaccine shows promise in early-phase clinical trial europeanpharmaceuticalreview
December 10, 2020
The chimeric hemagglutinin (HA)-based vaccine induced a strong, functional immune response that lasted at least 18 months.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page